Showing results (301-310 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|July 24, 2001
Gastrointestinal-related healthcare resource usage associated with a fixed combination of diclofenac and misoprostol versus other NSAIDsE Rahme, L Joseph, S X Kong, et al.
Pharmacoeconomics|July 24, 2001
Lifestyle drugs: determining their value and who should payD Mitrany
Pharmacoeconomics|July 24, 2001
The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998C E Begley, J F Annegers, A C Swann, et al.
Pharmacoeconomics|July 24, 2001
Cost effectiveness of ramipril in patients with non-diabetic nephropathy and hypertension: economic evaluation of Ramipril Efficacy in Nephropathy (REIN) Study for Germany from the perspective of statutory health insuranceP K Schädlich, J G Brecht, M Brunetti, et al.
Pharmacoeconomics|July 18, 2001
Torasemide: a pharmacoeconomic review of its use in chronic heart failureM Young, G L Plosker
Pharmacoeconomics|January 31, 2021
Multiple Myeloma in Portugal: Burden of Disease and Cost of IllnessManuel Neves, Fernanda Trigo, Bergantim Rui, et al.
Pharmacoeconomics|September 19, 2019
Can You Repeat That? Exploring the Definition of a Successful Model Replication in Health EconomicsEmma McManus, David Turner, Tracey Sach
Pharmacoeconomics|October 2, 2019
A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness AnalysisSandjar Djalalov, Jaclyn Beca, Emmanuel M Ewara, et al.
Pharmacoeconomics|January 19, 2021
NICE's Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial InterestsJames F O'Mahony, Mike Paulden, Chris McCabe
Pharmacoeconomics|March 15, 2011
Economic burden of renal cell carcinoma: Part I--an updated reviewYa-Chen T Shih, Chun-Ru Chien, Ying Xu, et al.
Pageof 335